JCI table of contents, June 8, 2006


HtrA1 protein contributes to the development of resistance to chemotherapy in ovarian and gastric cancers

While many cancer patients initially have a favorable response to chemotherapy for the treatment of solid tumors, resistance to treatment often develops. Resistance can be caused by many factors, including metabolism of the drug, a decrease in drug accumulation in tumor cells, altered expression of molecules involved in cell death, or further DNA mutation or modification that makes the drug ineffective. In a study appearing online on June 8 in advance of print publication in the July issue of the Journal of Clinical Investigation, Viji Shridhar and colleagues from the Mayo Clinic College of Medicine show that 2 antitumor agents, cisplatin and paclitaxel, increase the expression of the protein HtrA1 in ovarian carcinoma cells, which induces cell death. Conversely, reduced HtrA1 expression reduced the effectiveness of cisplatin and paclitaxel.

The authors went on to test whether the level of HtrA1 expression could predict the response to chemotherapy of patients with ovarian or gastric cancer receiving cisplatin-based chemotherapy. The authors found that patients with ovarian or gastric tumors expressing higher levels of HtrA1 showed a better response to chemotherapy compared to those with lower levels of HtrA1 expression. The study reveals a novel pathway by which HtrA1 mediates the ability of chemotherapeutic agents to kill cancer cells, and suggests that loss of HtrA1 in ovarian and gastric cancer may contribute to the development of resistance to chemotherapy.

TITLE: Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity

Elizabeth Zimmermann
Communications, Mayo Clinic Cancer Center, Rochester, Minnesota, USA.
Phone: (507) 284-5005; E-mail: newsbureau@mayo.edu.

View the PDF of this article at:

Contact: Brooke Grindlinger
Journal of Clinical Investigation

Page: 1 2 3 4 5

Related medicine news :

1. International symposium on fruit, vegetables headed for Houston
2. Stevens Roundtable: Health, Technology & Society, July 11
3. FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma
4. Once-fatal metabolic disorders treatable, says Stanford/Packard researcher
5. Clinical review -- A psychological approach to the management of irritable bowel syndrome
6. JCI table of contents -- May 17, 2007
7. JCI table of contents: May 10, 2007
8. New treatments needed for irritable bowel syndrome
9. JCI table of contents: May 1, 2007
10. Americans still not eating enough fruits and vegetables, according to 2 recent studies
11. Slow-release morphine reduces level of intractable cough

Post Your Comments:

(Date:4/2/2020)... ... ... LifeLearn Animal Health , in partnership with the North American Veterinary Community ... COVID-19: What we know and don’t know with Dr. Scott Weese , available ... important for practices and pet owners to get the facts,” says Dr. Mark Stephenson, ...
(Date:4/1/2020)... CHURCH, Va. (PRWEB) , ... April 02, 2020 , ... ... - 3:00 p.m. EDT, https://www.fdanews.com/mdchangemanagement , What change management method should ... — the method is often dependent on the type of change. Is it due ...
(Date:4/1/2020)... (PRWEB) , ... April 01, 2020 , ... ... and private of information under California law,” says Keller Grover LLP attorney Eric ... timely notice of data breaches and the negligent release and disclosure of medical ...
(Date:3/28/2020)... , ... March 27, 2020 , ... ... and the public from the spread of the coronavirus. Operating under the designation ... pressing forward with infrastructure renewal and environmental protection projects in the downstate New ...
(Date:3/27/2020)... ... March 27, 2020 , ... Justin P. Kubeck, ... Docs. Dr. Kubeck has been approved every year consecutively since 2016. Dr. Kubeck ... Spinal Surgery. , Dr. Kubeck’s medical education began at Thomas Jefferson University. ...
Breaking Medicine News(10 mins):
(Date:3/27/2020)... ... March 27, 2020 , ... Nexus, ... is changing its name to Nexus Family Healing. For more than 45 years, ... and families suffering from mental, emotional and behavioral issues. Moving forward, Nexus Family ...
(Date:3/27/2020)... ... ... Shady Grove Fertility (SGF) —home to more than 85,000 babies born—now ... virtual physician consults , thereby minimizing interruptions in access to fertility care during this ... has always been to improve access to care. We’re pleased to be able to ...
(Date:3/22/2020)... ... 2020 , ... As the spread of Coronavirus (COVID-19) continues ... Medicine and Surgery, and the Temple Lung Center have taken proactive steps to ... and triage/care coordination services. Temple is now enrolling patients, faculty, staff, frontline workers ...
Breaking Medicine Technology:
Cached News: